A randomised, single blind, controlled trial to evaluate the safety and efficacy of a home-based exercise programme to manage cancer-related fatigue for women recently diagnosed with gynaecological cancer

niversity of Ulster (UK)0 sites60 target enrollmentJuly 25, 2008

Overview

No summary available.

Registry

who.int

Start Date

July 25, 2008

End Date

TBD

Last Updated

8 years ago

Study Type

Interventional

Sex

Female

Sponsor

niversity of Ulster (UK)

•1\. Women aged 18 years old or over
•2\. Recently diagnosed with stages 0 \- III gynaecological cancer
•3\. Completed surgery and are currently receiving radiotherapy or chemotherapy or have completed anti\-cancer treatment and are less than one year post anti\-cancer treatment
•4\. Reporting mild, moderate or severe fatigue based on a numeric rating scale (where 0 \= no fatigue and 10 \= worst fatigue you can imagine)
•5\. Currently sedentary (exercising less than once a week for 20 minutes at a vigorous intensity or less than two times per week for 30 minutes at moderate intensity or less than 20 minutes three times per week, for the past six months)
•6\. Ambulatory and without use of a walking aid
•7\. Willing to be randomised

•1\. Have any medical or current psychiatric illness that could make compliance with the study protocol difficult or dangerous (e.g., unstable cardiovascular disease, hypertension, diabetes, respiratory disease, severe mental illness, cognitive dysfunction or orthopaedic problems that would limit exercise training)
•2\. Previously diagnosed with a fatigue\-related co\-morbid medical condition (fibromyalgia, chronic fatigue syndrome, multiple sclerosis (MS), myalgic encephalopathy (ME), lupus or arthritis)
•3\. History of cancer, i.e., not treatment naive
•4\. Participating in other intervention trials